Skip to main content

Table 3 Nonspecific diagnostic criteria for HSCT-TMA

From: Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy

Parameter

Blood and Marrow Transplant Clinical Trials Network (2005) [37]

International Working Group (2007) [38]

Overall TMA grouping (2010) [39]

City of Hope (2013) [40]

American Society of Hematology–European Society for Blood and Marrow Transplantation (2014) [41]

Jodele criteria (2014) [29]

Pediatric

Schistocytes

√

√

√

√

√

√

Elevated LDH

√

√

√

√

√

√

Thrombocytopenia

 

√

√

√

√

√

Decreased hemoglobin

 

√

√

 

√

√

Negative Coombs test

√

 

√

 

√

 

Increased serum creatinine

√

  

√

  

Decreased haptoglobin

 

√

√

   

Elevated soluble C5b-9

    

√

√

Proteinuria

    

√

√

Hypertension

    

√

√

Other

Neurologic dysfunction

   

TA-TMA Index ≥ 20

 
  1. LDH Lactate dehydrogenase, HSCT-TMA Hematopoietic stem cell transplantation-associated thrombotic microangiopathy, TA-TMA Transplant-associated thrombotic microangiopathy, TMA Thrombotic microangiopathy
  2. √ = presence of parameter in HSCT-TMA diagnostic criteria